ArticleJournal of feline medicine and surgery2025
Progression of lipase activity and pancreatic lipase immunoreactivity in clinically healthy cats and cats with diet-responsive enteropathy.
Article in Journal of feline medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Serial measurement of serum pancreatic lipase immunoreactivity and trypsin-like immunoreactivity concentrations in cats with chronic enteropathy.Journal of feline medicine and surgery · 2026Article
- Longitudinal comparison of serum pancreatic lipase activity and pancreatic lipase immunoreactivity with clinical signs in cats with suspicion of pancreatitis.Journal of feline medicine and surgery · 2026Article
- Unsupervised clustering of serum lipase activity in cats: a data-driven approach to correlate clinical, laboratory, and ultrasonographic findings.Journal of veterinary internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivesThe aim of the present study was to describe the course of lipase activity, pancreatic lipase immunoreactivity (PLI) and clinical findings over time in cats.MethodsFour clinically healthy cats and two diarrhoeic cats from a research colony aged 2-8 years with normal haematology and serum biochemistry results were followed up with lipase measurements over a total of 12 months in this descriptive study. Lipase activity (LIPCRoche; reference interval [RI] 8-26 U/l) was determined at day 0, and lipase activity and concurrent PLI (Spec fPL; RI 0-4.4 µg/l) were determined at days 19, 47, 54, 221 and 369. All cats were examined weekly. The pancreas and gastrointestinal tract of all cats were examined via ultrasonography.ResultsLipase activity and PLI in four clinically healthy cats was in the range of 10-283 U/l (median 69) and 1.2-86 µg/l (median 13), respectively. Lipase activity and PLI in two cats with enteropathy was in the range of 16-130 U/l (median 42) and 1.9-36 µg/l (median 8.3). The magnitude and nature of change were always the same for both assays. The correlation between assays was very high (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.